Stay updated with the latest national-pharmaceutical-pricing-authority news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on national-pharmaceutical-pricing-authority topics.
Indore: India's pharmaceutical sector is facing a slowdown due to the ongoing conflict between the United States, Israel, and Iran. Apart from petrol and LPG gas, the war has led to an increase in the prices of raw materials used in drug manufacturing as well, particularly those sourced from China. The cost has gone up between 40% and 100%, which is expected to disrupt supply chains. According to JP Mulchandani, President of the Basic Drug Dealers Association, Indore, the Indian pharmaceutical ...Read More >
BENGALURU: AICC General Secretary Randeep Singh Surjewala here on Tuesday lashed out at the Centre as it increased prices of 900 essential medicines, including those for diabetes, hypertension and infectious diseases that will come into effect from April 1. The Modi government and National Pharmaceutical Pricing Authority (NPPA) are increasing the prices of 31 medicines including that for diabetes and prophylactic Merofen 500 mg used in ICUs. It has imposed a 12% GST despite demand for GST exem ...Read More >
Bengaluru, March 31 (SocialNews.XYZ) The Congress on Tuesday launched a scathing attack on the Bharatiya Janata Party-led Central Government over a fresh wave of price hikes set to take effect on April 1. Addressing a joint press conference at the KPCC headquarters in Bengaluru, AICC general secretary Randeep Singh Surjewala and Karnataka deputy Chief Minister DK Shivakumar categorized the new fiscal year as a "day of loot, rob, and fleece" for the hardworking citizens of the country. Surjewal ...Read More >
New Delhi [India], September 16 (ANI): Consumers will get the benefits of reduced GST on medicines that have been manufactured and on chemist shelves before the new rates are implemented from September 22. The sweeping GST reforms unveiled on September 3, among other measures by the central government, have provided a substantial relief on health care, with taxes being either fully exempted or brought down to the lowest slab. Since then, there has been a widespread query about what will happen ...Read More >
New Delhi, Sep 13 (PTI) The National Pharmaceutical Pricing Authority has asked pharmaceutical companies and medical device makers to pass on the benefit of reduced GST rates to consumers with effect from September 22. "The benefit of reduction in GST rates shall be passed on to consumers/patients effective from September 22, 2025. All the manufacturers /marketing companies selling drugs/formulations shall revise the MRP of drugs/formulations (including medical devices) accordingly, with effect ...Read More >
New Delhi, Sep 13 (SocialNews.XYZ) The Association of Indian Medical Device Industry (AiMeD) on Saturday welcomed the timely directions issued by the Department of Pharmaceuticals (DoP), National Pharmaceutical Pricing Authority (NPPA) and the Central Drugs Standard Control Organisation (CDSCO) to ensure smooth implementation of the revised GST rates on drugs, formulations, and medical devices, effective from September 22. The Office Memorandum issued by DoP-NPPA on Friday clarified that while ...Read More >
New Delhi, Aug 3: In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies. The formulations, which will now cost less, span a wide range of medicines including anti-inflammatory, cardiovascular, antibiotic, anti-diabetic and psychiatric medicines. The Ministry of Chemicals and Fertilisers notified the order based on price regulation by the NPPA. Th ...Read More >
In a move to boost affordability, the government on Saturday fixed retail prices of a range of essential drugs. The Ministry of Chemicals and Fertilisers notified the move through a detailed order covering 35 medicines marketed by top pharmaceutical companies. The notification aims to ensure affordable access to essential medicines through price regulation by the National Pharmaceutical Pricing Authority (NPPA). The pricing decision was made under the provisions of the Drugs (Prices Control) ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.